Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis
The FASEB Journal · 2025
DOI: 10.1096/fj.202500305rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Shuo Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Peritoneal Fibrosis, Peritoneal Dialysis, Oxidative Stress, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Science Fundation for Young Scholars of China, Science and Technology Development Plan Program of Medicine and Health of Shandong Province, Jinan Science and Technology Development Plan Clinical Medicine Technology Innovation Plan.
Abstract (Originalsprache)
The transcription factor PU.1 has been implicated in various fibrotic diseases; however, its role in peritoneal dialysis‐associated peritoneal fibrosis (PF) remains unclear. The role of PU.1 was investigated using knockdown approaches with AAV9‐shPU.1 in a rat PF model and siRNA in human peritoneal mesothelial cells (MeT‐5A). Multiple experimental techniques, including real‐time quantitative PCR, western blot, enzyme‐linked immunosorbent assay (ELISA), and immunohistochemical staining, were utilized. In vivo, PU.1 expression was significantly upregulated in the rat PF model. Knockdown of PU.1 ameliorated peritoneal thickening, collagen deposition, angiogenesis, inflammation, and oxidative stress. In vitro, high‐glucose exposure upregulated PU.1 expression in MeT‐5A cells, promoting fibrosis and angiogenesis. PU.1 knockdown reduced fibrosis‐related markers and suppressed the IL‐6/JAK1/STAT3 signaling pathway, a critical regulator of PF. Treatment with an IL‐6 inhibitor further confirmed that PU.1 modulates fibrosis through this pathway. PU.1 plays a pivotal role in the progression of PF. Its knockdown mitigates fibrosis by reducing inflammation and angiogenesis, and suppressing the activation of the IL‐6/JAK1/STAT3 pathway, highlighting its potential as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
- Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
- Department of Nephrology, Yanzhou District People's Hospital, Jining, Shandong, China.
- Department of Nephrology, The People's Hospital of Zouping City, Binzhou, Shandong, China.
- Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
ORCID-Profile: Jie Gao, Haiping Wang
Förderung
- National Science Fundation for Young Scholars of China
- Science and Technology Development Plan Program of Medicine and Health of Shandong Province
- Jinan Science and Technology Development Plan Clinical Medicine Technology Innovation Plan
- Shandong Provincial Natural Science Foundation General Project
- Young Scientist Fund Training Program of Shandong First Medical University (Shandong Academy of Medical Sciences)
- Shandong Academy of Medical Sciences
Zitieren
APA
Zhong, S., Su, W., Wang, Y., Liu, D., Li, X., Ma, F., Xu, L., Gao, J., Wang, H., & Sun, J. (2025). Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202500305rr
Vancouver
Zhong S, Su W, Wang Y, Liu D, Li X, Ma F, et al. Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis. The FASEB Journal. 2025. doi:10.1096/fj.202500305rr
BibTeX
@article{Zhong2025,
author = {Zhong, Shuo and Su, Wenyan and Wang, Yunzhao and Liu, Dan and Li, Xiumei and Ma, Fangzhou and Xu, Liang and Gao, Jie and Wang, Haiping and Sun, Jing},
title = {Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500305rr}
}
EUVIMED